Literature DB >> 2664545

Linear accelerator radiosurgery of cerebral arteriovenous malformations.

F Colombo1, A Benedetti, F Pozza, C Marchetti, G Chierego.   

Abstract

A technique for linear accelerator radiosurgery has been used in clinical practice since 1982. The technique is based on multiple intersecting arc irradiations focused on a stereotactic target. From November 1984 to October 1988, 97 patients with cerebral arteriovenous malformations have been treated. Seventy-nine patients suffered one or more than one hemorrhage. Four patients had progressive neurological symptoms. In 14 patients, epilepsy was the principal complaint. Stereotactic localization was performed by stereotactic angiography. Lesion dimensions varied from 4 to 40 mm in diameter. Doses from 18.7 to 40 Gy were delivered in one or two sessions. Mean follow-up is 17.1 months (from 1 to 49). Four instances of minor rebleeding were observed after treatment; 3 patients complained of transient neurological deterioration. Of 56 patients who were followed longer than 1 year, 50 underwent 12-month follow-up angiography. In 26 patients complete obliteration of the malformation was demonstrated (52%), in 12 patients subtotal obliteration was obtained (24%), in 11 patients the obliteration was evident but not significant (22%), and in 1 patient the AVM was unchanged. Other angiographic features in incompletely obliterated cases were a significant reduction of flow velocity through the malformation together with a reduction in diameter of both feeding arteries and draining veins.

Entities:  

Mesh:

Year:  1989        PMID: 2664545     DOI: 10.1227/00006123-198906000-00008

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  15 in total

1.  Stereotactic radiosurgery for brain arteriovenous malformations: quantitative MR assessment of nidal response at 1 year and angiographic factors predicting early obliteration.

Authors:  S Nagaraja; K J Lee; S C Coley; D Capener; L Walton; A A Kemeny; I D Wilkinson; P D Griffiths
Journal:  Neuroradiology       Date:  2006-08-31       Impact factor: 2.804

2.  Treatment of type D dural carotid-cavernous fistula by embolization followed by irradiation.

Authors:  L Pierot; M Poisson; M Jason; D Pontvert; J Chiras
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

3.  Stereotactic linac radiosurgery for arteriovenous malformations.

Authors:  B G Kenny; E R Hitchcock; G Kitchen; A E Dalton; D A Yates; S V Chavda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

4.  Developing areas and their cost-benefit correlations: radiosurgery.

Authors:  F Colombo
Journal:  Childs Nerv Syst       Date:  1995-01       Impact factor: 1.475

5.  Stereotactically guided radiosurgery using the linear accelerator.

Authors:  S Blond; B Coche-Dequeant; B Castelain
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Stereotactic diagnosis and treatment of pineal region tumours and vascular malformations.

Authors:  P K Dempsey; D Kondziolka; L D Lunsford
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

7.  Brain arteriovenous malformations: assessment with dynamic MR digital subtraction angiography.

Authors:  P D Griffiths; N Hoggard; D J Warren; I D Wilkinson; B Anderson; C A Romanowski
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

Review 8.  Spinal radiosurgery: technology and clinical outcomes.

Authors:  M Avanzo; P Romanelli
Journal:  Neurosurg Rev       Date:  2008-09-24       Impact factor: 3.042

Review 9.  Conventional fractionated radiation therapy vs. radiosurgery for selected benign intracranial lesions (arteriovenous malformations, pituitary adenomas, and acoustic neuromas).

Authors:  L B Marks
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

Review 10.  The combined management of cerebral arteriovenous malformations. Experience with 100 cases and review of the literature.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; Y Bascoulergue; D Amat
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.